Clinical Trial

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2023 (before its estimated March 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to follow the progress of wounds in those with venous leg ulcers and diabetic foot ulcers while using an absorbent dressing called Mepilex Up. The main objective is to follow the progress of these wounds over time from initial visit to each follow-up visit. Participants will be asked to wear Mepilex Up dressing for up to 6 weeks of treatment or until healed, changed at every one-week interval.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-18; most recent amendment 2025-02-20.
Status change: Recruiting → Completed 2025-02-20
Status change: Not Yet Recruiting → Recruiting 2022-11-07
Trial Details
NCT Number NCT05588583
Lead Sponsor Molnlycke Health Care AB
Conditions Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer
Enrollment 68 participants
Start Date 2022-10-31
Primary Completion 2024-03 (estimated)
Study Completion 2024-03 (estimated)
Updated on ClinicalTrials.gov 2023-04-20